Budesonide MMX in the Treatment of Ulcerative Colitis: Current Perspectives on Efficacy and Safety
Giovanni Maconi, Deborah Camatta, Rosanna Cannatelli, Francesca Ferretti, Anna Carvalhas Gabrielli, Sandro Ardizzone Gastroenterology Unit, Department of Biomedical and Clinical Sciences FBF – L.Sacco, University Hospital, Milan, ItalyCorrespondence: Giovanni MaconiGastroenterology Unit, D...
Enregistré dans:
Auteurs principaux: | Maconi G, Camatta D, Cannatelli R, Ferretti F, Carvalhas Gabrielli A, Ardizzone S |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ebee08982e6e4a13aa4ae5fb39b5cb2a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Melilotus officinalis L. Protects Ulcerative Colitis in Rats
par: Hajar Khazraei, et autres
Publié: (2015) -
Antioxidant and Anti-Inflammatory Effects of Gel and Aqueous Extract of Melilotus officinalis L. in Induced Ulcerative Colitis: A Rattus norvegicus Model
par: Ali Reza Safarpour, et autres
Publié: (2015) -
Is histological remission of ulcerative colitis achievable?
par: Oleg V. Knyazev, et autres
Publié: (2021) -
Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?
par: Viscido A, et autres
Publié: (2019) -
Colitis linfocítica en paciente con colitis ulcerosa: Caso clínico
par: Estay,Camila, et autres
Publié: (2016)